UNSPSC 41181942: Tumor polypeptide antigen (tpa - incl. tps) tests

In this classification, a Tumor polypeptide antigen (tpa - incl. tps) tumor associated antigen immunological test system that consists of the reagents used to identify by immunochemical techniques Tumor polypeptide antigen (tpa - incl. tps) based tumors.

UNSPSC 41181942 Tumor polypeptide antigen (TPA—including TPS) tests is a Commodity code with minimal recent state and local procurement activity directly aligned to the code's nominal scope. The recent opportunities tagged with this code span laboratory testing and equipment services that diverge significantly from tumor marker immunoassays—Marion County, Oregon solicited general laboratory testing and phlebotomy services for custody populations; Texas DSHS sought repair and maintenance for laboratory equipment (washers and sterilizers); Lubbock Power & Light requested insulating oil analysis for electrical equipment; and the City of Orlando posted a sole-source notice for technical support on a fluoride analyzer system. None of these procurements involve TPA or tumor polypeptide antigen testing. The misalignment between the code label and actual buying activity suggests the code either sees sparse legitimate demand or is being applied inconsistently by issuing bodies. No representative TPA-specific test opportunities appear in the dataset, and no pattern of issuing body types (county health departments, state laboratories, or hospital systems) focused on oncology or tumor marker screening emerges.

The geographic spread reflected in the recent opportunities spans Oregon, Texas, and Florida, with no concentration of tumor marker testing demand visible. Without concrete evidence of active procurement for TPA or TPS assays under this code in state and local markets, this category presents minimal targeting opportunity at present. Business development professionals should monitor for actual tumor marker testing solicitations from state public health laboratories, county health departments, or state-affiliated cancer centers, but should not expect significant volume under this code designation based on current activity.